Biopticon Corporation is categorized under Medical Apparatus and Supplies in Camden, NJ and active since 2004.
Biopticon Corporation was established in 2004, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Apparatus and Supplies business, which does work in the B2C market, and is classified as a Medical Apparatus and Supplies, under code number 446199 by the NAICS.
If you are seeking more information, feel free to contact Cem Girit at the company’s single location by writing to 200 Federal St # 223, Camden, New Jersey NJ 08103 or by phoning (609) 275-0321. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Biopticon Corporation |
| Contact Person: | Cem Girit |
| Address: | 200 Federal St # 223, Camden, New Jersey 08103 |
| Phone Number: | (609) 275-0321 |
| Website Address: | biopticon.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2004 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Apparatus and Supplies |
| SIC Code: | 5999 |
| NAICS Code: | 446199 |
| Share This Business: |
Biopticon Corporation was started in 2004 to provide professional Medical Apparatus and Supplies under the SIC code 5999 and NAICS code 446199. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Cem Girit for inquiries that concern Biopticon Corporation by calling the company number (609) 275-0321, as your correspondence is most welcome. Additionally, the physical location of the single location of Biopticon Corporation can be found at the coordinates 39.944301,-75.127006 as well as the street address 200 Federal St # 223 in Camden, New Jersey 08103.
For its online presence, you may visit Biopticon Corporation’s website at biopticon.com and engage with its social media outlets through on Twitter and on Facebook.